Using deuterium in drug discovery: leaving the label in the drug.

Deuterium, the stable isotope of hydrogen, is known to medicinal chemists for its utility in mechanistic, spectroscopic, and tracer studies. In fact, well-known applications utilizing deuterium exist within every subdiscipline in pharmaceutical discovery and development. Recent emphasis on incorporation of deuterium into the active pharmaceutical ingredient has come about as a result of inquiries into the potential for substantial benefits of the deuterium kinetic isotope effect on the safety and disposition of the drug substance. This Perspective traces the author's experience in reviving and expanding this potential utility, first suggested many decades prior by the discoverer of this, the simplest of all isotopes.

[1]  M. Harnett,et al.  A Randomized Phase I Evaluation of CTP‐499, a Novel Deuterium‐Containing Drug Candidate for Diabetic Nephropathy , 2013, Clinical pharmacology in drug development.

[2]  P. Hollenberg,et al.  Bioactivation of the Cancer Chemopreventive Agent Tamoxifen to Quinone Methides by Cytochrome P4502B6 and Identification of the Modified Residue on the Apoprotein , 2012, Drug Metabolism and Disposition.

[3]  Lijun Wu,et al.  Design and Rationale for Randomized, Doubleblind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Patients With Diabetic Nephropathy (DN) , 2012 .

[4]  S. Harbeson,et al.  Deuterium in Drug Discovery and Development , 2011 .

[5]  R. O'ferrall A pictorial representation of zero-point energy and tunnelling contributions to primary hydrogen isotope effects , 2010 .

[6]  D. Valentine Isotopic remembrance of metabolism past , 2009, Proceedings of the National Academy of Sciences.

[7]  Timothy S Tracy,et al.  Polymorphic Variants of CYP2C9: Mechanisms Involved in Reduced Catalytic Activity , 2007, Molecular Pharmacology.

[8]  J. Zimmermann,et al.  The renaissance of H/D exchange. , 2007, Angewandte Chemie.

[9]  V. Schramm Binding isotope effects: boon and bane. , 2007, Current opinion in chemical biology.

[10]  R. Obach,et al.  What is the Objective of the Mass Balance Study? A Retrospective Analysis of Data in Animal and Human Excretion Studies Employing Radiolabeled Drugs , 2007, Drug metabolism reviews.

[11]  H. Sajiki,et al.  Aromatic ring favorable and efficient H-D exchange reaction catalyzed by Pt/C , 2005 .

[12]  R. Baldwin Imaging MAO-A levels by PET using the deuterium isotope effect. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  R. Armstrong,et al.  Insights into enzyme structure and dynamics elucidated by amide H/D exchange mass spectrometry. , 2005, Archives of biochemistry and biophysics.

[14]  J. Adams The proteasome: a suitable antineoplastic target , 2004, Nature Reviews Cancer.

[15]  H. Sajiki,et al.  Efficient C-H/C-D exchange reaction on the alkyl side chain of aromatic compounds using heterogeneous Pd/C in D2O. , 2004, Organic letters.

[16]  W. Eisenreich,et al.  Systematics of 2H patterns in natural compounds and its importance for the elucidation of biosynthetic pathways , 2004, Phytochemistry Reviews.

[17]  R. Robins,et al.  Measurement of 2H distribution in natural products by quantitative 2H NMR: An approach to understanding metabolism and enzyme mechanism? , 2004, Phytochemistry Reviews.

[18]  G. Martin,et al.  Climatic significance of isotope ratios , 2004, Phytochemistry Reviews.

[19]  W. Trager,et al.  The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[20]  F. Rastinejad,et al.  Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. , 2003, Cancer research.

[21]  R. Obach,et al.  Drug Metabolizing Enzymes : Cytochrome P450 and Other Enzymes in Drug Discovery and Development , 2003 .

[22]  S. Previs,et al.  Measuring in vivo metabolism using heavy water , 2003, Current opinion in clinical nutrition and metabolic care.

[23]  S. Knowles,et al.  Reactive metabolites and adverse drug reactions , 2003, Clinical reviews in allergy & immunology.

[24]  W. Cleland,et al.  The use of isotope effects to determine enzyme mechanisms. , 2003, The Journal of biological chemistry.

[25]  C. Kettner,et al.  Synthesis of boronic acid analogues of alpha-amino acids by introducing side chains as electrophiles. , 2001, The Journal of organic chemistry.

[26]  E. Topol,et al.  Risk of cardiovascular events associated with selective COX-2 inhibitors. , 2001, JAMA.

[27]  John Hodgson,et al.  ADMET—turning chemicals into drugs , 2001, Nature Biotechnology.

[28]  M. Sutcliffe,et al.  Deuterium Isotope Effects during Carbon–Hydrogen Bond Cleavage by Trimethylamine Dehydrogenase , 2001, The Journal of Biological Chemistry.

[29]  A. Delsemme 1999 KUIPER PRIZE LECTURE: Cometary Origin of the Biosphere , 2000 .

[30]  S. Scheiner Calculation of isotope effects from first principles. , 2000, Biochimica et biophysica acta.

[31]  P. Brzezinski Proton-transfer reactions in bioenergetics. , 2000, Biochimica et biophysica acta.

[32]  L. Krishtalik The mechanism of the proton transfer: an outline. , 2000, Biochimica et biophysica acta.

[33]  C. Tommos,et al.  Proton and hydrogen currents in photosynthetic water oxidation. , 2000, Biochimica et biophysica acta.

[34]  François Robert,et al.  The Solar System d/h Ratio: Observations and Theories , 2000 .

[35]  F. Guengerich,et al.  WHAT MAKES P450s WORK? SEARCHES FOR ANSWERS WITH KNOWN AND NEW P450s* , 2000, Drug metabolism reviews.

[36]  H. Ohta,et al.  The first synthesis of both enantiomers of [α-2H]phenylacetic acid in high enantiomeric excess , 2000 .

[37]  E. Perez-stable,et al.  Ethnic differences in N-glucuronidation of nicotine and cotinine. , 1999, The Journal of pharmacology and experimental therapeutics.

[38]  S. Daniels,et al.  Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial. , 1999, Clinical therapeutics.

[39]  D. Kushner,et al.  Pharmacological uses and perspectives of heavy water and deuterated compounds. , 1999, Canadian journal of physiology and pharmacology.

[40]  M. Fava,et al.  Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial , 1998, Biological Psychiatry.

[41]  M. Rowlands,et al.  The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen. , 1995, Carcinogenesis.

[42]  S. Venitt,et al.  Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. , 1994, Carcinogenesis.

[43]  D A Schoeller,et al.  Measurement of energy expenditure in free-living humans by using doubly labeled water. , 1988, The Journal of nutrition.

[44]  G. Darland,et al.  Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine. , 1986, Drug metabolism and disposition: the biological fate of chemicals.

[45]  Z. E. Kahana Synthesis and applications of isotopically labeled compounds : edited by William P. Duncan and Alexander B. Susan, Elsevier, 1983. US$ 110.75 (xxviii + 508 pages) ISBN 0 444 42152 1 , 1984 .

[46]  A. G. Horgan,et al.  Structure of the reaction barrier in the selenoxide-mediated formation of olefins , 1981 .

[47]  S. Scheppele Kinetic isotope effects as a valid measure of structure-reactivity relations. Isotope effects and nonclassical theory , 1972 .

[48]  R. G. Taecker,et al.  Deep‐tank culture of blue‐green algae in H2O and D2O , 1971 .

[49]  J. Katz,et al.  The biosynthesis of isotope hybrid proteins for high resolution nuclear magnetic resonance studies by incorporation of [1H]amino acids into fully deuterated algae. , 1970, Biochimica et biophysica acta.

[50]  L. Bartell,et al.  Electron‐Diffraction Study of the Structures of C2H4 and C2D4 , 1965 .

[51]  F. Westheimer The Magnitude of the Primary Kinetic Isotope Effect for Compounds of Hydrogen and Deuterium. , 1961 .

[52]  J. Katz,et al.  Isolation of Fully Deuterated Metabolites from Scenedesmus obliquus Grown in Deuterium Oxide , 1961 .

[53]  J. F. Thomson PHYSIOLOGICAL EFFECTS OF D2O IN MAMMALS * , 1960 .

[54]  J. Katz,et al.  CHLOROPLAST PIGMENTS AND PHOTOSYNTHESIS IN DEUTERATED GREEN ALGAE * , 1960 .

[55]  J. Katz,et al.  CYTOCHEMICAL STUDIES ON DEUTERATED GREEN ALGAE * , 1960, Annals of the New York Academy of Sciences.

[56]  S. Wellings,et al.  Growth of HeLa cells in heavy water. , 1960, Experimental cell research.

[57]  J. Katz,et al.  Culture of Algae and other Micro-organisms in Deuterium oxide , 1959, Nature.

[58]  Stanley L. Miller,et al.  Organic Compound Synthes on the Primitive Eart: Several questions about the origin of life have been answered, but much remains to be studied , 1959 .

[59]  L. J. Schaad,et al.  Use of Hydrogen Isotope Effects to Identify the Attacking Nucleophile in the Enolization of Ketones Catalyzed by Acetic Acid1-3 , 1958 .

[60]  M. Itoh,et al.  DIE WIRKUNG DES VERDÜNNTEN SCHWEREN WASSERS AUF DIE TUBERKELBAZILLEN , 1935 .